Click to copy, then share by pasting into your messages, comments, social media posts and websites.
Click to copy, then add into your webpages so users can view and engage with this video from your site.
Report Content
We also accept reports via email. Please see the Guidelines Enforcement Process for instructions on how to make a request via email.
Thank you for submitting your report
We will investigate and take the appropriate action.
$6.5-Billion ‘Baby Powder-Cancer’ Settlement Proposal Pushed Forward by Johnson and Johnson - FULL
Headquartered in New Jersey, Johnson and Johnson is one of the largest pharmaceutical companies in the world. It’s also one of the handful of companies that made a windfall during the pandemic with their vaccine. In fact, the Janssen shot was making the company upwards of $740 million dollar per quarter—that was, of course, before the shot was pulled off the market due to an elevated risk of serious blood clots in vaccine recipients.
However, having their vaccine pulled off the market might be the least of Johnson and Johnson’s financial worries. That’s because just yesterday, the company announced a willingness to pay $6.5 billion dollar in order to settle nearly all of the lawsuits in America claiming that their baby powder (and talcum powder products) caused people to develop cancer.
Once enacted, this settlement will be the 4th largest in US history, right behind the $7.2 billion dollar that Enron had to pay after defrauding their shareholders.
However, aside from the magnitude of the dollar amount itself, the story of how this $6.5-billion settlement came to be—as well as the legal maneuvering that Johnson and Johnson has been doing behind the scenes to try and shield themselves from lawsuits—is fascinating to say the least.
Source:
The Epoch Times, Facts Matter, May 3, 2024
https://www.theepochtimes.com/epochtv/6-5-billion-baby-powder-cancer-settlement-proposal-pushed-forward-by-johnson-and-johnson-facts-matter-5642486
Episode Resources:
🔵 Johnson Statement:
https://www.jnj.com/media-center/press-releases/johnson-johnson-announces-plan-by-its-subsidiary-llt-management-llc-to-resolve-all-current-and-future-ovarian-cancer-talc-claims-through-a-consensual-prepackaged-reorganization
🔵 Latest Moves:
https://www.theepochtimes.com/business/johnson-johnson-proposes-6-5-billion-payment-to-resolve-majority-of-ovarian-cancer-lawsuits-linked-to-talc-powder-5641903
🔵 Reuters Investigation:
https://www.reuters.com/investigates/special-report/johnsonandjohnson-cancer/
🔵 Legal Maneuvers:
https://www.axios.com/2021/10/19/johnson-johnson-texas-baby-powder-gambit
https://www.reuters.com/investigates/special-report/johnsonandjohnson-cancer/
https://www.cnbc.com/2021/10/19/covid-and-johnson-johnson-jnj-earnings-q3-2021.html
https://www.reuters.com/legal/government/us-supreme-court-declines-hear-jj-appeal-over-2-billion-baby-powder-judgment-2021-06-01/
Related content:
A guiding hand on talc safety research
https://www.reuters.com/investigates/special-report/johnsonandjohnson-cancer/#johnson-research
Read the documents cited in the Reuters article
https://www.documentcloud.org/app?q=%2Bproject%3Ajohnson-johnson-40934
After damaging Reuters report, J&J doubles down on talc safety message, January 1, 2019
https://www.reuters.com/article/us-johnson-johnson-cancer-crisis/after-damaging-reuters-report-jj-doubles-down-on-talc-safety-message-idUSKCN1OU16D/
Category | None |
Sensitivity | Normal - Content that is suitable for ages 16 and over |
Playing Next
Related Videos
Effects of N1-Methyl-Pseudouridine in the Pfizer mRNA Vaccine - Amy Kelly
1 week, 3 days ago
WHO’s Global Power Grab – Part 1
2 weeks, 3 days ago
WHO Global Power Grab - PART 1 PREVIEW (9mins)
2 weeks, 3 days ago
Warning - This video exceeds your sensitivity preference!
To dismiss this warning and continue to watch the video please click on the button below.
Note - Autoplay has been disabled for this video.